
Marker Therapeutics director Steve Elms acquires $35,472 in stock
Published on December 26, 2024
an indirect ownership of 325,370 shares, which are directly owned by Aisling Capital IV, LP, where Elms shares voting and dispositive power.
Other news

an indirect ownership of 325,370 shares, which are directly owned by Aisling Capital IV, LP, where Elms shares voting and dispositive power.